These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11786169)

  • 1. Toxic epidermal necrolysis incriminating iopamidol in a child after cardiac catheterization.
    Lee ML; Chiu IS
    Int J Cardiol; 2002 Jan; 82(1):95-7. PubMed ID: 11786169
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxic epidermal necrolysis - an investigation to dye for?
    Ridley LJ; Limaye S
    Med J Aust; 2015 Jul; 203(2):76-8. PubMed ID: 26175241
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxic epidermal necrolysis - an investigation to dye for?
    Ly T; Stewart N; Lee S
    Med J Aust; 2015 Jan; 202(1):51-2. PubMed ID: 25588447
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent toxic epidermal necrolysis secondary to iopromide contrast.
    Brown M; Yowler C; Brandt C
    J Burn Care Res; 2013; 34(1):e53-6. PubMed ID: 22929525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probable parenteral and oral contrast-induced Steven Johnson syndrome/toxic epidermal necrolysis.
    Pop M; Hemenway A; Shakeel F
    Am J Emerg Med; 2021 Jul; 45():684.e5-684.e6. PubMed ID: 33402308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stevens-Johnson syndrome and toxic epidermal necrolysis in Togo: the role of self-medication].
    Saka B; Kombaté K; Egbohou P; Mouhari-Toure A; Akakpo S; Boukari T; Tchangaï-Walla K; Pitché P
    Ann Dermatol Venereol; 2012 Jun; 139(6-7):486-7. PubMed ID: 22721483
    [No Abstract]   [Full Text] [Related]  

  • 8. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)].
    Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B
    Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
    Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review.
    Gerull R; Nelle M; Schaible T
    Crit Care Med; 2011 Jun; 39(6):1521-32. PubMed ID: 21358399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Toxic epidermal necrolysis (syndrome Lyell) versus Stevens-Johnson syndrome].
    Jezierska-Krupa B; Hyla-Klekot L
    Pediatr Pol; 1996 Jul; 71(7):615-20. PubMed ID: 8803466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Erythema multiforme exudativum, Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell's syndrome) and their interrelationship].
    Kalamkarian AA; Samsonov VA
    Vestn Dermatol Venerol; 1980 Mar; (3):36-42. PubMed ID: 6990649
    [No Abstract]   [Full Text] [Related]  

  • 13. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Prendiville J
    Adv Dermatol; 2002; 18():151-73. PubMed ID: 12528405
    [No Abstract]   [Full Text] [Related]  

  • 14. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs causing severe ocular surface involvements in Japanese patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Kaniwa N; Ueta M; Nakamura R; Okamoto-Uchida Y; Sugiyama E; Maekawa K; Takahashi Y; Furuya H; Yagami A; Matsukura S; Ikezawa Z; Matsunaga K; Sotozono C; Aihara M; Kinoshita S; Saito Y
    Allergol Int; 2015 Oct; 64(4):379-81. PubMed ID: 26433536
    [No Abstract]   [Full Text] [Related]  

  • 16. Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Cartotto R
    Clin Plast Surg; 2017 Jul; 44(3):583-595. PubMed ID: 28576247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic epidermal necrolysis and Stevens-Johnson syndrome: things we should know!
    Kamolz LP; Spendel S; Prandl EC
    Crit Care Med; 2011 Jun; 39(6):1600-1. PubMed ID: 21610649
    [No Abstract]   [Full Text] [Related]  

  • 18. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Should Be Kept in Mind in Children with Febrile Neutropenia, Oral Cavity Lesions, and Skin Rash.
    Ataseven E; Yılmaz Bengoa Ş; Ören H
    Turk J Haematol; 2016 Jun; 33(2):170-1. PubMed ID: 26376920
    [No Abstract]   [Full Text] [Related]  

  • 19. Fatal Stevens-Johnson syndrome following urography with iopamidol in systemic lupus erythematosus.
    Savill JS; Barrie R; Ghosh S; Muhlemann M; Dawson P; Pusey CD
    Postgrad Med J; 1988 May; 64(751):392-4. PubMed ID: 3200783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.